Pfizer announces deal with Canada for experimental COVID-19 vaccine

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 31 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 66%

Singapore Headlines News

Singapore Latest News,Singapore Headlines

OTTAWA: Pharmaceutical giant Pfizer and German biotech firm BioNTech on Wednesday (Aug 5) said they had signed a deal to supply Canada with an ...

OTTAWA: Pharmaceutical giant Pfizer and German biotech firm BioNTech on Wednesday said they had signed a deal to supply Canada with an experimental coronavirus vaccine.

Deliveries of the BNT162 mRNA-based vaccine candidate are planned over the course of 2021, subject to clinical success and Health Canada approval, the two companies said in a statement. They did not reveal financial details.READ: Moderna in talks to supply countries with COVID-19 vaccine; US$32-$37 a dose for smaller deals

Separately, the Canadian government said it would make an announcement on the next steps in procuring vaccines later on Wednesday. There are no approved vaccines for the illness caused by the coronavirus, but 19 vaccines are being tested in humans around the world.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in SG

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Moderna says discussing supply deals with countries for COVID-19 vaccineModerna Inc said on Wednesday it has started talks with several countries for supply agreements for its experimental coronavirus vaccine and has ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Moderna says discussing supply deals with countries for Covid-19 vaccineBANGALORE (REUTERS) - Moderna said on Wednesday (Aug 5) it has started talks with several countries for supply agreements for its experimental coronavirus vaccine and has received about US$400 million (S$548 million) in deposits for potential supply.. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »

Novavax reports promising early trial results of COVID-19 vaccineUS biotech company Novavax on Tuesday announced its experimental COVID-19 vaccine elicited a robust immune response, producing more antibodies than are present in recovered patients, and with generally tolerable side-effects in its early-stage trial. The company was given $1.6 billion by the US government
Source: YahooSG - 🏆 3. / 71 Read more »

Bill Gates urges US to help poorer countries get Covid-19 vaccinesWASHINGTON (BLOOMBERG) - Microsoft Corp founder and philanthropist Bill Gates urged the US to take a more global approach in dealing with the coronavirus pandemic, saying while the nation leads in research, 'we've only taken care of ourselves' in producing and procuring a vaccine.. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »

Indonesia to have capacity to produce 250 million doses of COVID-19 vaccine a yearJAKARTA: Indonesia will have capacity to produce 250 million doses a year of a coronavirus vaccine by the end of 2020 pending trials on humans, a ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

UK invests $25 million in Scottish Covid-19 vaccine siteLONDON (BLOOMBERG) - The UK has agreed to invest in a Scottish factory that will make French biotech firm Valneva's Covid-19 vaccine, in a move to secure domestic production of the shot.. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »